Final Rule Paves Way for Drug Imports to Reduce Patient Costs

The Department of Health and Human Services and the Food and Drug Administration have issued a final rule and guidance that paves the way for states to allow pharmacists and wholesalers to import prescription drugs in order to reduce costs for patients. The final rule implements a provision of federal law that allows FDA-authorized programs to import [...]

By | 2020-10-27T16:07:59-07:00 October 27th, 2020|Uncategorized|0 Comments

Large PBMs Balk at Push to Reduce Drug Prices

In a move that exemplifies the potential conflict of interest that some large pharmacy benefit managers have, the nation’s largest PBM earlier this year said it would demand that rebates remain unchanged when drug makers roll out new price cuts. Drug makers earlier in the year said they would start reducing prices as well as [...]

By | 2019-11-19T12:16:12-08:00 November 19th, 2019|Uncategorized|0 Comments

Proposed Rules Would Affect Prescription Drug Plans

The Centers for Medicare and Medicaid Services has floated proposed regulations that would affect drug benefits for group plans and association plans and attempt to reduce drug expenses for health plan enrollees and drug plans. While the rules seem to be focused on individual plans sold on government-run exchanges, three of the changes would also [...]

By | 2019-06-25T12:48:47-07:00 June 25th, 2019|Healthcare|0 Comments

New Law Bars Pharmacy Benefit Manager Gag Clauses

President Trump has signed two bills into law that would add transparency to drug pricing by banning gag clauses imposed by pharmacy benefit managers (PBMs) that bar pharmacists from discussing drug prices with the person buying prescription medication. The bills, passed with bipartisan support, take aim at the PBM practice of clawbacks, which occur when [...]

By | 2019-06-18T11:07:46-07:00 June 18th, 2019|Healthcare|0 Comments